- Home
- FTFT vs PSTV Comparison
FTFT vs PSTV Comparison
Compare FTFT & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- PSTV
- Stock Information
- Founded
- FTFT N/A
- PSTV 1996
- Country
- FTFT United States
- PSTV United States
- Employees
- FTFT N/A
- PSTV N/A
- Industry
- FTFT Business Services
- PSTV Medical/Dental Instruments
- Sector
- FTFT Consumer Discretionary
- PSTV Health Care
- Exchange
- FTFT Nasdaq
- PSTV Nasdaq
- Market Cap
- FTFT 6.2M
- PSTV 7.1M
- IPO Year
- FTFT N/A
- PSTV N/A
- Fundamental
- Price
- FTFT $0.24
- PSTV $1.20
- Analyst Decision
- FTFT
- PSTV Strong Buy
- Analyst Count
- FTFT 0
- PSTV 2
- Target Price
- FTFT N/A
- PSTV $13.50
- AVG Volume (30 Days)
- FTFT 320.7K
- PSTV 33.2K
- Earning Date
- FTFT 04-15-2025
- PSTV 03-04-2025
- Dividend Yield
- FTFT N/A
- PSTV N/A
- EPS Growth
- FTFT N/A
- PSTV N/A
- EPS
- FTFT N/A
- PSTV N/A
- Revenue
- FTFT $18,543,659.00
- PSTV $5,725,000.00
- Revenue This Year
- FTFT N/A
- PSTV $32.12
- Revenue Next Year
- FTFT N/A
- PSTV N/A
- P/E Ratio
- FTFT N/A
- PSTV N/A
- Revenue Growth
- FTFT N/A
- PSTV 52.63
- 52 Week Low
- FTFT $0.23
- PSTV $0.93
- 52 Week High
- FTFT $1.28
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- FTFT 40.48
- PSTV 48.71
- Support Level
- FTFT $0.23
- PSTV $1.18
- Resistance Level
- FTFT $0.28
- PSTV $1.30
- Average True Range (ATR)
- FTFT 0.02
- PSTV 0.09
- MACD
- FTFT 0.00
- PSTV -0.00
- Stochastic Oscillator
- FTFT 13.20
- PSTV 45.42
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).